Belite Bio (BLTE) Research & Development (2022 - 2026)
Belite Bio's Research & Development came in at $18.21 million for Q2 2026, up 64.8% from $11.05 million a year earlier and up 16.3% from the prior quarter.
Powered by 
Analysis
Belite Bio (BLTE) Research & Development (2022 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Belite Bio reported Research & Development of $44.18 million, up 61.9% year-over-year; for FY2025, it was $45.38 million, up 51.6% from FY2024.
- Research & Development has increased in each of the last five years, with a five-year compound annual growth rate of 65.2% (FY2020 to FY2025).
- Going back by year, Research & Development was $29.94 million in FY2024 (+20.5%), $24.84 million in FY2023 (+180.1%), $8.87 million in FY2022 (+19.5%) and $7.42 million in FY2021 (+101.2%).
- The Q2 2026 figure represents the highest quarterly Research & Development in data going back to Q1 2022.
- Year-over-year, Research & Development has increased for six consecutive quarters, with growth averaging 27.8% over the last eight quarters.
- The fastest year-over-year change in Research & Development over five years came in Q3 2023 (growth of 637.8%), and the weakest in Q4 2024 (a decline of 100.0%).
- Business Quant data shows BLTE's Research & Development at $15.66 million (Q1 2026), $146.24 (Q4 2025) and $10.31 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Belite Bio | 6.53 Bn | 6.53 Bn | - | 18.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.21 Mn |
| Mar 31, 2026 | 15.66 Mn |
| Dec 31, 2025 | 146.24 |
| Sep 30, 2025 | 10.31 Mn |
| Jun 30, 2025 | 11.05 Mn |
| Mar 31, 2025 | 9.40 Mn |
| Dec 31, 2024 | 72.54 |
| Sep 30, 2024 | 6.84 Mn |
| Jun 30, 2024 | 9.08 Mn |
| Mar 31, 2024 | 6.77 Mn |
| Dec 31, 2023 | 4.86 Mn |
| Sep 30, 2023 | 8.74 Mn |
| Jun 30, 2023 | 55.16 |
| Mar 31, 2023 | 5.72 Mn |
| Dec 31, 2022 | 5.23 Mn |
| Sep 30, 2022 | 1.19 Mn |
| Jun 30, 2022 | 1.58 Mn |
| Mar 31, 2022 | 878,000.00 |
API Access
Belite Bio Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=BLTE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "BLTE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=BLTE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();